| abstract |
The present invention relates to a cancer diagnostic or anticancer screening composition comprising an antibody against a FLJ25416 gene or a protein expressed from the FLJ25416 gene, an inhibitor of the gene or an inhibitor of the protein expressed from the gene and a cancer comprising a pharmaceutically acceptable carrier. Provided are a kit for diagnosing cancer comprising at least one of a therapeutic composition, a FLJ25416 gene, or a protein expressed from the FLJ25416 gene. Since the FLJ25416 gene of the present invention is expressed in large amounts in specific cancer cells and increases the proliferation rate of normal cells, inhibiting the expression of these genes has an effect of inhibiting the growth of cancer cells. Therefore, the FLJ25416 gene can be used as a target gene for diagnosis or treatment of various cancers.n n n n FLJ25416, cancer, siRNA |